Cargando…
Evaluation of Epic® label-free technology to quantify functional recombinant hemagglutinin
BACKGROUND: Alternative methods are being sought to measure the potency of influenza vaccines. Label-free technologies that do not require the use of hemagglutinin (HA)-specific antisera are particularly attractive as the preparation of antiserum delays availability of potency reagents. The objectiv...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359790/ https://www.ncbi.nlm.nih.gov/pubmed/25774096 http://dx.doi.org/10.1186/s12575-015-0019-5 |